Media Coverage

The Associated Press spotlights its behind-the-scenes work covering the 2025 Nobel Prize, using global collaboration and exclusive access – from a pre-dawn knock at Dr. Mary Brunkow’s door to multimedia teamwork worldwide – to deliver prompt, emotionally charged storytelling.

In her CBC conversation, Mary Brunkow reflects on the surprise of receiving the 2025 Nobel Prize and the collaborative journey behind her groundbreaking work on immune-system regulation. She recounts how the discovery of the FOXP3 gene – stemming from studies of the “scurfy” mouse model – helped unlock the mystery of how regulatory T cells prevent the body from attacking itself.

In an in-person interview on KOMO News’ ARC Seattle, Nobel laureate Mary Brunkow recounts the early-morning call from Stockholm and discusses the FOXP3 discovery’s impact.

In an interview with NPR’s Here & Now, Dr. Mary Brunkow reflects on the scurfy mouse, finding FOXP3, and the clinical promise of T regs – explained for a general audience in a concise, ~6-minute segment with host Scott Tong.

In this ~20-minute interview, KUOW’s Soundside host Gabriel Spitzer talks with Nobel laureate Mary Brunkow about the “scurfy” mouse, discovering FOXP3, and how her work on immune tolerance is reshaping treatments for autoimmune disease and cancer

Chemical & Engineering News spotlights the Nobel-driven science behind regulatory T cells (Tregs) and how the discovery of FOXP3 helped spark a wave of biotech startups tackling autoimmune diseases and cancer.

A friendly, plain-English explainer of the immune system’s “peacekeepers” – regulatory T cells – tracing how FOXP3 flips them on, how they prevent self-attack, and why that science landed Mary Brunkow and colleagues on Nobel morning.

Before dawn knocks and “spam” calls turn real, Mary Brunkow steps into the spotlight – reflecting on the discovery of regulatory T cells that reshaped care for autoimmune disease, cancer, and transplants, from her Darwin Molecular days to ISB today.